Skip to main content
Sansure Biotech Inc. logo

Sansure Biotech Inc. — Investor Relations & Filings

Ticker · 688289 ISIN · CNE1000043J1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2020-12-07 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688289

About Sansure Biotech Inc.

https://www.sansureglobal.com/

Sansure Biotech Inc. specializes in the development and manufacture of molecular diagnostic products and genetic testing solutions. The company utilizes proprietary technologies, such as the "One-tube" fast extraction method and advanced magnetic bead technology, to provide high-sensitivity PCR diagnostic kits. Its product portfolio covers a wide range of clinical applications, including infectious disease screening for hepatitis, respiratory infections, and sexually transmitted infections, as well as oncology and maternal health. Sansure also provides integrated laboratory automation systems, including nucleic acid extractors and real-time PCR instruments, designed to streamline clinical workflows and improve diagnostic efficiency for healthcare providers and research institutions globally.

Recent filings

Filing Released Lang Actions
科技股份有限公司关于自愿披露公司相关检测产品获得欧盟CE认证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the voluntary disclosure of certain products obtaining EU CE certification. It details product names, certificate numbers, application fields, and validity periods. It also discusses potential market competition risks and profit impact uncertainties. There is no financial data, no mention of annual or quarterly reports, no voting results, no management changes, no earnings release, or other financial filings. The document is an official announcement about product certification and related risks, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories and is a regulatory-type announcement.
2020-12-07 Chinese
2020年季度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the distribution of quarterly dividends for the year 2020 by 圣湘生物科技股份有限公司. It details the dividend amount per share, relevant dates for record, ex-dividend, and payment, the shareholders entitled to the dividend, tax treatment, and contact information for inquiries. The document is not a full financial report but a specific announcement about dividend distribution. It is relatively short (2483 characters) and focuses solely on dividend payment details. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2020-11-26 Chinese
湖南启元律师事务所关于圣湘生物科技股份有限公司2020年第三次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and validity of the procedures, attendance, and voting results of the 2020 third extraordinary general meeting of shareholders of 圣湘生物科技股份有限公司. It details the convening, attendance, voting procedures, and results of the shareholders' meeting, confirming compliance with relevant laws and company articles. The document does not contain financial statements or performance data, nor is it a report or announcement of financial results. It is a legal opinion related to a shareholders' meeting and its voting outcomes. This fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially documents the voting results and validates the meeting's legality.
2020-11-18 Chinese
2020年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from the company's third extraordinary general meeting of shareholders in 2020. It details the meeting date, attendance, voting results on specific proposals including the appointment of a new director and a cash dividend plan, and includes legal witness statements confirming the validity of the meeting and resolutions. There is no detailed financial data or comprehensive report content, but rather an official announcement of voting results from a shareholders meeting. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting outcomes, not a full report or presentation.
2020-11-18 Chinese
关于与私募基金合作投资进展的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by 圣湘生物科技股份有限公司 regarding the progress of its investment subscription in a limited partnership equity investment fund (苏州金阖二期股权投资合伙企业). It details the subscription amount, fund establishment date, and payment progress. The document is short (1040 characters) and focuses on investment progress updates rather than financial results or detailed financial statements. It does not contain financial statements or detailed financial analysis, nor is it a report or presentation. It is an update on a capital investment activity, specifically about the company's investment in a fund and payment progress. Therefore, it fits best under Capital/Financing Update (CAP).
2020-11-16 Chinese
关于自愿披露公司相关产品获得美国FDA授权的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the voluntary disclosure of FDA authorization for certain products. It includes details about the products, their approval status, potential market competition risks, and uncertainties about profit impact. The document is relatively short (1309 characters) and does not contain financial statements or detailed financial data. It is an announcement about a regulatory approval event rather than a financial report or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-11-16 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.